Mitek to Report Fourth Quarter and Fiscal 2016 Financial Results on November 3, 2016
Oct 27, 2016 20:11 pm UTC| Business
SAN DIEGO, Oct. 27, 2016 -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader in mobile capture and identity verification software solutions, today announced that it will release its financial results for the...
Adesto Technologies Announces Third Quarter Financial Results
Oct 27, 2016 20:11 pm UTC| Business
SANTA CLARA, Calif., Oct. 27, 2016 -- Adesto Technologies Corporation (NASDAQ:IOTS), a leading provider of application-specific, feature-rich, ultra-low power non-volatile memory products, today announced financial...
LinkedIn Announces Third Quarter 2016 Results
Oct 27, 2016 20:10 pm UTC| Business
MOUNTAIN VIEW, Calif., Oct. 27, 2016 -- LinkedInCorporation (NYSE:LNKD), the world's largest professional network on the Internet, today reported results for the third quarter of 2016. Detailed financial information on...
LinkedIn Announces Third Quarter 2016 Results
Oct 27, 2016 20:10 pm UTC| Business
MOUNTAIN VIEW, Calif., Oct. 27, 2016 -- LinkedInCorporation (NYSE:LNKD), the world's largest professional network on the Internet, today reported results for the third quarter of 2016. Detailed financial information on...
LinkedIn Announces Third Quarter 2016 Results
Oct 27, 2016 20:10 pm UTC| Business
MOUNTAIN VIEW, Calif., Oct. 27, 2016 -- LinkedInCorporation (NYSE:LNKD), the world's largest professional network on the Internet, today reported results for the third quarter of 2016. Detailed financial information on...
Integer Holdings Corporation Reports 2016 Third Quarter Results
Oct 27, 2016 20:10 pm UTC| Business
FRISCO, Texas, Oct. 27, 2016 -- Integer Holdings Corporation (NYSE:ITGR), today announced results for the three months ended September30, 2016. Third Quarter 2016 Executive Summary Revenue of $347 million, an...
TESARO Announces Acceptance for Review of Niraparib Marketing Authorization Application by EMA
Oct 27, 2016 20:10 pm UTC| Business
WALTHAM, Mass., Oct. 27, 2016 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the Marketing Authorisation Application (MAA) for niraparib has been submitted to and...